Single Center Experience With Impella 5.5 for Escalation and De-Escalation of Cardiogenic Shock Patients
Temporary mechanical circulatory support (tMCS) devices are a critical component for treating patients with cardiogenic shock (CS). We analyzed use of Impella 5.5 device for efficacy and safety in a single-center CS population from February 2022 and April 2023. Thirty-six CS patients received Impell...
Saved in:
| Main Authors: | Ioana Dumitru, Debbie Rinde-Hoffman, Maria Sevillano, Leeandra Schnell, Elizabeth Quintilliani, Swaroop Bommareddi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Interventional Cardiology |
| Online Access: | http://dx.doi.org/10.1155/joic/7044608 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Impella RP Flex in Post-Heart Transplant Patients with RV Primary Graft Dysfunction
by: Ioana Dumitru, et al.
Published: (2025-05-01) -
Impella 5.5 as a bridge-to-surgery in acute ischemic mitral regurgitation post-percutaneous coronary intervention: a case report
by: Ioana Dumitru, et al.
Published: (2024-11-01) -
Recognizing Post-Cardiac Injury Syndrome After Impella 5.5 Insertion in Cardiogenic Shock: A Case-Based Discussion
by: Aarti Desai, et al.
Published: (2025-07-01) -
Transinnominate Impella 5.5 insertion as a bridge to transplantation in a pediatric patient in refractory cardiogenic shockCentral Message
by: Ismail Bouhout, MD, PhD, et al.
Published: (2022-08-01) -
Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
by: Pratik K. Dalal, et al.
Published: (2019-01-01)